Sequential measurement of intratumoral platinum concentration in cervix uterine tumors after cis-dichlorodiammineplatinum (CDDP) administration.
Intratumoral (cervix uterine tumors) distribution of platinum was studied in ten patients after IV administration of CDDP. Sequential tumoral measurement of platinum was carried out 4, 24, and 48 h after the IV infusion. Platinum concentration in the tumor samples ranged from 0 to 29,5 ng/mg tissue. For all patients, there was no definite evolution of the tumoral concentration with time and there was no good relation for the same patient between the platinum concentration in three successive biopsies. These results involve uncertainty in studies attempting to relate CDDP tumor levels (measured in one biopsy) and tumor response to chemotherapy.
D002945:Cisplatin / Q000627:therapeutic use*; D005260:Female; D006801:Humans; D010984:Platinum / Q000032:analysis*; D013997:Time Factors; D002583:Uterine Cervical Neoplasms / Q000032:analysis*
D010984:Platinum; D002945:Cisplatin